InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ghmm post# 543

Thursday, 02/11/2010 3:37:32 PM

Thursday, February 11, 2010 3:37:32 PM

Post# of 3990
GENZ started two phase III trials for eliglustat in Aug. and Estimated Study Completion Date is December 2011 for both. I'm sure they'll be looking at bone improvement.
PLX technology allows them to take a gene, (theoretically any gene), insert and express it in plant cells and get a recombinant product. As for how long it takes, between a couple of months to a year for a known gene. But then comes the hard part - see if the protein works properly...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News